Advertisement

Spine Conditions

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA
FDA
FDA Approves Treatment for Neuromyelitis Optica Spectrum Disorder
08/17/2020
The US Food and Drug Administration has approved a new treatment for neuromyelitis optica spectrum disorder among adults with the AQP4 antibody.
08/17/2020
Spinal Muscular Atrophy
Spinal Muscular Atrophy
FDA Approves Option for Spinal Muscular Atrophy
08/10/2020
The US Food and Drug Administration has approved an oral drug for the treatment of spinal muscular atrophy among patients aged 2 years or older.
08/10/2020